Abiopharma

News list

FDA updates labeling for NORGESTIMATE AND ETHINYL ESTRADIOL

FDA Approval
Jan. 09, 2026, 09:53 UTC

Labeling changes approved for MYLAN. Active ingredient: ETHINYL ESTRADIOL; NORGESTIMATE. Decision date: 01/07/2026

Full text

Register to leave comments
There are no comments here yet...